Spectrum of movement disorders associated with glutaric aciduria type 1: A study of 16 patients
Authors:
- Cyril GitiauxCGCyril Gitiaux
- Emmanuel RozeEREmmanuel Roze
- Kiyoka KinugawaKKKiyoka Kinugawa
- Constance Flamand‐RouvièreCFConstance Flamand‐Rouvière
- Nathalie BoddaertNBNathalie Boddaert
- David DevosDDDavid Devos
- 29 September 2008
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 23 (16) , 2392-2397
Abstract
Glutaric aciduria type 1 (GA1) is an autosomal recessive neurometabolic disorder due to glutaryl CoA dehydrogenase deficiency. Comprehensive descriptions of GA1‐associated movement disorders are rare. In order to refine the description of the motor phenotype, we prospectively studied 16 consecutive pediatric and adult GA1 patients, focusing on the movement disorders and their time course. In most patients, generalized dystonia, superimposed on baseline axial hypotonia, remained the predominant feature throughout the disease course. With aging, it tended to evolve from mobile to fixed dystonia and to be associated with akinetic‐rigid parkinsonism. Prominent orofacial involvement was a consistent feature in GA1 patients with movement disorders, resulting in speech disorders with features of combined hyperkinetic dysarthria and speech apraxia. The types and outcome of movement disorders in this setting should be taken into consideration during rehabilitation and for patient selection and evaluation in therapeutic trials. © 2008 Movement Disorder SocietyKeywords
This publication has 26 references indexed in Scilit:
- Guideline for the diagnosis and management of glutaryl‐CoA dehydrogenase deficiency (glutaric aciduria type I)Journal of Inherited Metabolic Disease, 2007
- Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase DeficiencyPediatric Research, 2006
- Glutaric aciduria type I: Outcome in the Republic of IrelandJournal of Inherited Metabolic Disease, 2004
- Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1European Journal of Paediatric Neurology, 2004
- Pathomechanisms of neurodegeneration in glutaryl‐CoA dehydrogenase deficiencyAnnals of Neurology, 2003
- Type I glutaric aciduria, part 1: Natural history of 77 patientsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2003
- Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically DistinctPediatric Research, 2000
- Movement disorders in childhood organic acidurias Clinical, neuroimaging, and biochemical correlationsBrain and Development, 1994
- Dystonia and dyskinesia in glutaric aciduria type I: Clinical heterogeneity and therapeutic considerationsMovement Disorders, 1994
- Glutaric aciduria; A “new” disorder of amino acid metabolismBiochemical Medicine, 1975